ALK Positive Inc.’s Post

Important discussion on primary #cancer prevention policies. Addressing cancer #inequalities in such policies is crucial to making prevention accessible for #everyone, regardless of socioeconomic barriers.

This month we celebrate the 1-year anniversary of the #NationalCancerPlan, a framework for collaboration guiding our nation’s efforts against cancer. Our Panel Chair, Dr. Elizabeth Jaffee, is live at #AACR24 discussing how our 5 priority areas outlined in the #NationalCancerPlan report underscore opportunities to accelerate progress in cancer care, research, & training. Learn more about our first assessment of the #NationalCancerPlan: https://bit.ly/3SXRB0D 

In our last video of the day, Abdelrahman Ali sat down with Jean-Bernard Durand,M.D. FACC,FACP,FCCP,FHFSA,FAHA,FHRS,FESC from MD Anderson Cancer Center about his talk at #GCOS2024 and what comes next. #gcos #cardioonc #cardioncology #cardiooncologia #cardiooncologie

Thanks so much, Stuart Lee, of Famous Faces Management , for the great conversation! It was a pleasure sharing insights on overcoming challenges and pushing beyond the limits of what we think is “average.” For anyone looking to be inspired and learn more about my journey, you can watch the full video here: https://zurl.co/5Pvo. Please send feedback 🙏 Stay strong and keep striving for excellence! #NoRetreatNoSurrender

The American Society of Clinical Oncology (ASCO) Annual Meeting is an important event in the oncology field, bringing together top researchers, trialists and clinicians to discuss groundbreaking cancer research and innovative therapies. Held from May 31 to June 4, 2024, in Chicago, this year’s meeting continues to highlight significant advancements, with respect to newer therapies and newer approaches in cancer care. Whether it was newer therapies, the use of previously unused combinations or investigative approaches like ctDNA, it had’em all. However, it’s crucial to make such influential events more accessible to professionals from low to middle-income countries (LMICs). Providing scholarships, virtual attendance options, and enhanced partnerships can bridge the gap, ensuring broader participation and fostering global collaboration in the fight against cancer. By expanding opportunities for all, we can drive forward the mission of health for all. #ASCO2024 #Oncology #CancerResearch #GlobalHealth

This weekend, the American Society of Clinical Oncology (ASCO) conference showcased ground-breaking advancements in the treatment of leukaemia and other haematological malignancies as well as a host of other cancers. A pivotal Phase 3 trial (the ASC4FIRST study) was presented, comparing the first in class drug asciminib with other tyrosine kinase inhibitors (TKIs) in newly diagnosed chronic myeloid leukaemia (CML) patients. The promising results provide evidence that asciminib could become potentially become a first-line treatment in CML, although longer- term follow up data will be needed first. Currently asciminib is available to certain CML patients if other two or more other TKIs have been tried first. Additionally, significant progress was showcased at ASCO in hematopoietic stem cell transplants. A Phase 1 study of STC-15, a METTL-3 inhibitor, showed encouraging results in patients with advanced malignancies, demonstrating safety and clinical activity. This lays the groundwork for Phase 2 trials later this year. Leukaemia UK has funded Dr Kostas Tzelepis's laboratory research at Cambridge on targeting METTL-3 in leukaemia in collaboration with STORM Therapeutics, which led this new trial. We are proud to support such pioneering laboratory work, which could help to underpin the development of potential new leukaemia treatments. https://lnkd.in/eQ3n8GnS #ASCO2024 #LeukemiaResearch #Oncology #Hematology #CancerTreatment #ClinicalTrials #InnovationInHealthcare

Heading to Washington, DC for the Association of Cancer Care Centers Annual Meeting & Cancer Center Business Summit next week? Don't miss Canopy's poster presentation! Discover firsthand how oncology practices are enhancing continuous care management with Canopy's Intelligent Care Platform. See you there! #AMCCBS #caremanagement #valuebasedcare #epro #chroniccaremanagement #Oncology #Cancer #HealthcareInnovation #CancerMoonshot

Last week we were privileged to attend the ESMO - European Society for Medical Oncology Congress in Barcelona. Elena Santana Martín and Elena Alcaraz Lara represented us at this important event that aims to improve the quality of cancer care, from prevention and diagnosis to palliative care and patient follow-up. 🌟 It was truly an honor to engage in discussions, share insights and exchange knowledge with experts in the field, as we are dedicated to driving innovation and sharing it with those who want to improve healthcare. At Naru, we are firm believers that the smarter the healthcare, the better. And we will continue to help build a more advanced, forward-thinking biomedicine. ↗↗↗ #ESMO24 #oncology #digitalhealth #saludinteligente #thesmarterthebetter #BiomedicinaDelFuturoHoy #BiomedicineOfTheFutureToday

This is why I do what I do: to help move the needle on truly important, impactful work such as that performed by the American Cancer Society. To support this mission, *and* engage in a deep dialogue with thought leaders, makes me quite fortunate. #impactinvesting #sustainablefinance #holtara